HER2 Support Group Forums
>
Search Forums
Search Results
User Name
Remember Me?
Password
Register
Gallery
FAQ
Members List
Calendar
Today's Posts
Search
Search Forums
Show Threads
Show Posts
Advanced Search
Search Gallery
Advanced Search
Go to Page...
Page 1 of 20
1
2
3
11
>
Last
»
Showing results 1 to 25 of 500
Search took
0.16
seconds.
Search:
Posts Made By:
Lani
Forum:
her2group
10-13-2021, 04:29 PM
Replies:
0
focused ultrasound delivers antibody therapy vs bc brain mets
Views:
3,579
Posted By
Lani
focused ultrasound delivers antibody therapy vs bc brain mets
ADVANCED SEARCH
EurekAlert! Science News A service of the American Association for the Advancement of Science
NEWS RELEASE 13-OCT-2021
World-first clinical trial demonstrates focused...
Forum:
her2group
09-18-2021, 12:31 AM
Replies:
1
HER2-targeting antibody-drug improves progression-free survival
Views:
4,285
Posted By
Lani
HER2-targeting antibody-drug improves progression-free survival
https://www.eurekalert.org/images/logo-2x.png (https://www.eurekalert.org/) https://www.eurekalert.org/images/brand.png (https://www.eurekalert.org/)
NEWS RELEASES...
Forum:
her2group
11-14-2020, 09:05 PM
Replies:
0
Final Efficacy Results of Neratinib in HER2+ER+ early bc
Views:
3,860
Posted By
Lani
Final Efficacy Results of Neratinib in HER2+ER+ early bc
full text links
https://cdn-ncbi-nlm-nih-gov.laneproxy.stanford.edu/corehtml/query/egifs/tools/DB__1__13__3140.gif (http://sfx.stanford.edu/local?sid=Entrez:PubMed&id=pmid:33183970)
actions...
Forum:
her2group
09-23-2020, 09:14 AM
Replies:
0
FDA APPROVES 1st PAN-TUMOUR LIQUID BIOPSY TEST FOR PATIENTS WITH ADVAnced CANCER
Views:
4,179
Posted By
Lani
FDA APPROVES 1st PAN-TUMOUR LIQUID BIOPSY TEST FOR PATIENTS WITH ADVAnced CANCER
FDA APPROVES FIRST COMPREHENSIVE PAN-TUMOUR LIQUID BIOPSY TEST FOR PATIENTS WITH ADVANCED CANCER
A qualitative next generation sequencing based in vitro diagnostic test analyzes more than 300...
Forum:
her2group
07-18-2020, 09:26 PM
Replies:
1
DE-ESCALATING TREATMENT FOR HER2+ early breast cancer
Views:
5,049
Posted By
Lani
DE-ESCALATING TREATMENT FOR HER2+ early breast cancer
Trans Am Clin Climatol Assocv.131; 2020PMC7358497
Trans Am Clin Climatol Assoc. 2020; 131: 119–126.
PMCID: PMC7358497
PMID: 32675852
DE-ESCALATING TREATMENT FOR HER2-POSITIVE EARLY BREAST...
Forum:
her2group
07-18-2020, 08:55 PM
Replies:
0
Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2+ Metastatic
Views:
2,814
Posted By
Lani
Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2+ Metastatic
Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Tria
J Clin Oncol
. 2020 Jul 17;JCO2000147. doi: 10.1200/JCO.20.00147. Online ahead of print.
Neratinib Plus...
Forum:
her2group
07-05-2020, 12:04 PM
Replies:
2
GREAT NEWS: FDA approves at home submit dual anti-her2/3 therapy
Views:
3,574
Posted By
Lani
GREAT NEWS: FDA approves at home submit dual anti-her2/3 therapy
can home hylecta be far behind?
FDA Approves In-home Breast Cancer Treatment
Advantageous for Infusion Centers?
Nick Mulcahy
June 29, 2020
Forum:
her2group
06-18-2020, 12:47 PM
Replies:
4
Tucatinib Is Active Against Brain Metastases in HER2+ Breast Cancer
Views:
6,380
Posted By
Lani
Tucatinib Is Active Against Brain Metastases in HER2+ Breast Cancer
Research Watch
Tucatinib Is Active Against Brain Metastases in HER2+ Breast Cancer
DOI: 10.1158/2159-8290.CD-RW2020-087
Forum:
her2group
05-31-2020, 06:38 PM
Replies:
1
Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2+ Brea
Views:
2,955
Posted By
Lani
Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2+ Brea
Breast Cancer With Brain Metastases in the HER2CLIMB Trial
J Clin Oncol
. 2020 May 29;JCO2000775. doi: 10.1200/JCO.20.00775. Online ahead of print.
Intracranial Efficacy and Survival With...
Forum:
her2group
05-01-2020, 10:24 PM
Replies:
1
Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus
Views:
3,090
Posted By
Lani
Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus
standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive stage 4 breast cancer
Lancet Oncol. 2020 Apr 27. pii: S1470-2045(20)30112-1. doi:...
Forum:
her2group
04-30-2020, 08:00 AM
Replies:
0
for those with lepto-meningeal mets
Views:
2,534
Posted By
Lani
for those with lepto-meningeal mets
J Neurooncol. 2020 Apr 29. doi: 10.1007/s11060-020-03510-y. [Epub ahead of print]
Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP...
Forum:
her2group
04-29-2020, 06:59 PM
Replies:
1
FDA approves tucatinib for Stage 4 her2+ breast cancer
Views:
2,691
Posted By
Lani
Re: FDA approves tucatinib for Stage 4 her2+ breast cancer
Cancer
CancerScope Free Access
Addition of tucatinib to trastuzumab and chemotherapy improves survival for patients with metastatic, HER2‐positive breast cancer
Carrie Printz
First published: 28...
Forum:
her2group
04-28-2020, 07:59 AM
Replies:
1
FDA approves tucatinib for Stage 4 her2+ breast cancer
Views:
2,691
Posted By
Lani
FDA approves tucatinib for Stage 4 her2+ breast cancer
U.S. Food and Drug Administration FDA approves tucatinib for patients with HER2-positive metastatic breast cancer
FDA approves tucatinib for patients with HER2-positive metastatic breast cancer...
Forum:
her2group
03-21-2020, 12:36 PM
Replies:
1
any hope of getting insurance companies to cover hylecta in view of covid19 pandemic?
Views:
2,747
Posted By
Lani
any hope of getting insurance companies to cover hylecta in view of covid19 pandemic?
utilizes. less hospital/clinic time, resources AND PERHAPS COULD BE GIVEN BY HOME HEALTH NURSES OR PCP office
thoughts?
Lani
Forum:
her2group
01-25-2020, 07:19 PM
Replies:
0
mtor inhibitor reverses resistance to neratinib
Views:
2,849
Posted By
Lani
mtor inhibitor reverses resistance to neratinib
NEWS RELEASE 23-JAN-2020
Researchers uncover two-drug combo that halts the growth of cancer cells
Discovery could counter resistance to promising new breast cancer therapy
UT SOUTHWESTERN...
Forum:
her2group
12-20-2019, 03:55 PM
Replies:
0
DS8201 accelerated approval by FDA
Views:
2,519
Posted By
Lani
DS8201 accelerated approval by FDA
HEALTH NEWSDECEMBER 20, 2019 / 10:47 PM / UPDATED AN HOUR AGO
AstraZeneca, Daiichi's breast cancer drug gets accelerated approval from FDA
2 MIN READ
FREUTERS/Brendan McDermid
(Reuters) - The...
Forum:
her2group
12-11-2019, 06:48 PM
Replies:
0
sabcs: Updated APHINITY Supports Benefit of Dual HER2 Blockade
Views:
2,276
Posted By
Lani
sabcs: Updated APHINITY Supports Benefit of Dual HER2 Blockade
www.medscape.com
Updated APHINITY Supports Benefit of Dual HER2 Blockade
Pam Harrison
December 11, 2019
SAN ANTONIO, Texas — An updated analysis of the APHINITY trial strengthens earlier...
Forum:
her2group
12-11-2019, 03:22 PM
Replies:
0
remarkable new drug for her2+mbc effective after many previous lines of treatment
Views:
2,565
Posted By
Lani
remarkable new drug for her2+mbc effective after many previous lines of treatment
HEALTH NEWSDECEMBER 11, 2019 / 2:12 PM / UPDATED 9 HOURS AGO
AstraZeneca-Daiichi drug halts cancer for months in first readout
(Reuters) - An experimental cancer drug developed by AstraZeneca and...
Forum:
her2group
12-11-2019, 09:51 AM
Replies:
1
SABCS: Tucatinib 'game changing' vs HER2+ MBC, especially w brain mets
Views:
2,554
Posted By
Lani
SABCS: Tucatinib 'game changing' vs HER2+ MBC, especially w brain mets
News Release 11-Dec-2019 Tucatinib 'game changing' against HER2+ breast cancer, especially with brain metastases
...
Forum:
her2group
12-07-2019, 01:39 PM
Replies:
0
Outcomes in HR+/HER2+ Metastatic Breast Cancer Pts: A Natnl Cancer Database Analysis
Views:
2,564
Posted By
Lani
Outcomes in HR+/HER2+ Metastatic Breast Cancer Pts: A Natnl Cancer Database Analysis
Format: Abstract
Send to
Sci Rep. 2019 Dec 2;9(1):18126. doi: 10.1038/s41598-019-54402-9.
Real-world Treatment Patterns and Outcomes in HR+/HER2+ Metastatic Breast Cancer Patients: A National...
Forum:
her2group
12-07-2019, 12:54 PM
Replies:
0
NSABP FB-7 paclitaxel + herceptin +/_neratinib
Views:
2,213
Posted By
Lani
NSABP FB-7 paclitaxel + herceptin +/_neratinib
NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2 + breast cancer | Breast Cancer...
Forum:
her2group
09-18-2019, 09:37 AM
Replies:
0
guide to treatment deescalation: her2 heterogeneity predicts response2 preop tdm1 &
Views:
2,729
Posted By
Lani
guide to treatment deescalation: her2 heterogeneity predicts response2 preop tdm1 &
pertuzumab combo
ASCO Reading Room 09.17.2019
HER2 Heterogeneity and Response to Neoadjuvant Therapy
Study confirms lower rates of HER2 expression, pCR in HER2+ breast cancer treated with...
Forum:
her2group
09-12-2019, 04:59 PM
Replies:
72
Whack-a-mole next...
Views:
46,856
Posted By
Lani
Re: Whack-a-mole next...
Vantage Logo May 08, 2019
Astra and Daiichi lay out their plan for a better Herceptin
Jacob Plieth
The companies’ DS-8201 succeeds in breast cancer patients who had failed Kadcyla, and...
Forum:
her2group
09-10-2019, 09:30 PM
Replies:
3
Lasker award to Drs Slamon, Ullrich, Shepard
Views:
4,714
Posted By
Lani
Lasker award to Drs Slamon, Ullrich, Shepard
www.medscape.com
Lasker Awards Honor Seminal Advances in Immunology, Breast Cancer
Megan Brooks
September 10, 2019
The 2019 winners of the Lasker Awards were announced today. The awards...
Forum:
her2group
09-06-2019, 10:31 AM
Replies:
72
Whack-a-mole next...
Views:
46,856
Posted By
Lani
Re: Whack-a-mole next...new target for "Lazarus effect"--keep up the hope
HEALTH NEWSSEPTEMBER 6, 2019 / 7:58 AM / UPDATED 4 HOURS AGO
Inside drugmakers' strategy to boost cancer medicines with 'Lazarus effect'
Julie Steenhuysen, Ludwig Burger
8 MIN READ
(Reuters) - In...
Showing results 1 to 25 of 500
Page 1 of 20
1
2
3
11
>
Last
»
Forum Jump
User Control Panel
Private Messages
Subscriptions
Who's Online
Search Forums
Forums Home
her2group
Herceptin / Tykerb
Caregivers Corner
Diet and Nutrition
Inflammatory Breast Cancer
Keeping Your Mind Off of BC
Profiles In Courage
My Healthcare Team
Clinical Trials
Articles of Interest
Events and Social Calendar
Breast Cancer Meeting Highlights
General Cancer News
Breast Cancer News
Breast Cancer Newsfeed
All times are GMT -7. The time now is
10:47 PM
.